Orthocell reports record $13.2 million annual revenue, driven by 36% quarterly growth in Remplir™ product sales. Orthocell Ltd (ASX:OCC) posted record revenue of $3.8 million for the June quarter, a 20% increase from the prior quarter and 36% higher year-over-year. The res
iShares MSCI Europe Financials ETF delivers higher income than State Street's U.S. bank ETF despite lower expense ratio for KBE. The iShares MSCI Europe Financials ETF (EUFN) paid $1.65 per share in distributions over the trailing 12 months, exceeding the yield of the Stat
Nancy Pelosi's disclosed trades yielded a 16,930% return over 37 years, surpassing the S&P 500's 2,300% gain. Nancy Pelosi's investment portfolio, managed by her husband, delivered a 16,930% cumulative return over her 37-year congressional tenure, compared to the S&P 500's
VTI, a low-cost ETF tracking the entire U.S. stock market, reaches $650 billion in assets with a 0.03% expense ratio. The Vanguard Total Stock Market ETF (VTI) has grown to over $650 billion in assets, making it one of the largest funds globally. It holds roughly 3,500 sto
Unum Group reduces long-term care exposure by 40% since last year with latest reinsurance agreement. Unum Group will reinsure an additional $3.8 billion of long-term care statutory reserves with Fortitude Re, increasing total reinsured reserves to $7 billion. The move cuts
An Invesco senior managing director disposed of 26,002 shares to cover tax liabilities, retaining a $3.5 million stake in the firm. Invesco Ltd. (IVZ) senior managing director Jeffrey H. Kupor sold 26,002 shares on July 2, 2026, at a weighted average price of $27.01, total
The sale of 8,491 shares by an Astera Labs insider occurred as the company reported $1.0 billion in trailing revenue and a $70 billion market cap. A director at Astera Labs sold 8,491 shares at a weighted average price of $458.38 on July 1, 2026, under a pre-arranged Rule
Jeff Bezos commits $2 billion as Blue Origin attracts $10 billion in outside capital, signaling confidence in its commercial space ambitions. Blue Origin has raised $10 billion in its first external funding round, valuing the company at $130 billion. Jeff Bezos is contribu
Chief Scientific Officer Harlan Robins sold 386,240 shares at $22.01 under a prearranged trading plan. Adaptive Biotechnologies Corporation’s Chief Scientific Officer Harlan S. Robins sold 386,240 shares for $8.5 million on July 2, 2026, at $22.01 per share. The transactio
Vanguard's tech ETF has delivered 25% annualized returns over 10 years, doubling the S&P 500's 10% average. The Vanguard Information Technology ETF (VGT) has averaged 25% annual returns over the past decade, outpacing the S&P 500's 10% long-term average. The fund's perform
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.